premature ovarian failure (premenopausal anovulation)

From Aaushi
Jump to navigation Jump to search

Introduction

Cessation of ovarian function under the age of 40 years

Etiology

Epidemiology

Genetics

Clinical manifestations

Laboratory

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Medical Knowledge Self Assessment Program (MKSAP) 11, 17, 19. American College of Physicians, Philadelphia 1998, 2015, 2023
  2. 2.0 2.1 OMIM https://mirror.omim.org/entry/300510
  3. Cordts EB, Christofolini DM, Dos Santos AA et al Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011 Mar;283(3):635-43 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21188402
  4. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod. 2002 Aug;17(8):2096-100. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12151443 Free Article
  5. Belvisi L, Bombelli F, Sironi L, Doldi N. Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest. 1993 Dec;16(11):889-92. PMID: https://www.ncbi.nlm.nih.gov/pubmed/8144865
  6. de Moraes Ruehsen M, Blizzard RM, Garcia-Bunuel R, Jones GS. Autoimmunity and ovarian failure. Am J Obstet Gynecol. 1972 Mar;112(5):693-703. PMID: https://www.ncbi.nlm.nih.gov/pubmed/4551032
  7. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997 Feb;18(1):107-34. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/9034788
  8. Kauffman RP, Castracane VD. Premature ovarian failure associated with autoimmune polyglandular syndrome: pathophysiological mechanisms and future fertility. J Womens Health (Larchmt). 2003 Jun;12(5):513-20. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12869299
  9. Mignot MH, Schoemaker J, Kleingeld M, Rao BR, Drexhage HA. Premature ovarian failure. I: The association with autoimmunity. Eur J Obstet Gynecol Reprod Biol. 1989 Jan;30(1):59-66. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2647538
    Mignot MH, Drexhage HA, Kleingeld M et al Premature ovarian failure. II: Considerations of cellular immunity defects. Eur J Obstet Gynecol Reprod Biol. 1989 Jan;30(1):67-72. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2647539
  10. Moncayo-Naveda H, Moncayo R, Benz R, Wolf A, Lauritzen C. Organ-specific antibodies against ovary in patients with systemic lupus erythematosus. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1227-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2729399
  11. 11.0 11.1 Ryan MM, Jones HR Jr. Myasthenia gravis and premature ovarian failure. Muscle Nerve. 2004 Aug;30(2):231-3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15266640
  12. Clines GA. Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):339-46. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2189722
  13. Legrand SB. Modern management of malignant hypercalcemia. Am J Hosp Palliat Care. 2011 Nov;28(7):515-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21724679

Database